TrialInternational journal of cardiology2013

Algisyl-LVR™ with coronary artery bypass grafting reduces left ventricular wall stress and improves function in the failing human heart.

Lik Chuan Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.